The Diagnostic Value of Serum L1CAM in Patients With Colorectal Cancer.

Abstract

OBJECTIVE:

Colorectal cancer is one of the most important malignant cancer in the world with high incidence and mortality. Some studies have found that the expression of low serum L1 cell adhesion molecule is associated with poor prognosis in some malignancies. It is suggested that L1 cell adhesion molecule is a candidate serum marker for certain tumors. However, the relationship between serum L1 cell adhesion molecule and colorectal cancer, especially about the diagnostic value, is rarely reported. Therefore, this study aimed to evaluate the diagnostic potential of serum L1 cell adhesion molecule in patients with colorectal cancer.

METHODS:

Enzyme-linked immunosorbent assay was carried out to detect L1 cell adhesion molecule level in sera of 229 patients with colorectal cancer and 145 normal controls. Receiver operating characteristic curves were employed to calculate the accuracy of diagnosis.

RESULTS:

The levels of serum L1 cell adhesion molecule in the colorectal cancer group were significantly lower than that in normal controls (P < .05). In the normal group, the area under the receiver operating characteristic curve (area under the curve) of all colorectal cancer was 0.781 (95% confidence interval: 0.734-0.828) and early-stage colorectal cancer was 0.764 (95% confidence interval: 0.705-0.823). With optimized cutoff of 17.760 ng/mL, L1 cell adhesion molecule showed certain diagnostic value with specificity of 90.3% and sensitivities of 43.2% and 36.2% in colorectal cancer and early-stage colorectal cancer, respectively. Clinical data analysis showed that the levels of L1 cell adhesion molecule were significantly correlated with gender (P < .05) and early and late stages (P < .05). Furthermore, when compared with carcinoembryonic antigen, serum L1 cell adhesion molecule had significantly improved diagnostic accuracy for both colorectal cancer and early-stage colorectal cancer.

CONCLUSIONS:

Our study demonstrated that serum L1 cell adhesion molecule might be served as a potential biomarker for the diagnosis of colorectal cancer.

• Authors: Ling-Yu Chu, Dong-Ming Guo, Jun-Tian Chen, Wang-Kai Fang, Jian-Jun Xie, Yu-Hui Peng, Yi-Wei Xu, Xin-Xin Li
• Journal: Technology in cancer research & treatment (Technol Cancer Res Treat) 2020 Jan-Dec Vol. 19 Pg. 1533033820920971 ISSN: 1533-0338 [Electronic] United States
• PMID: 32356487 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers, Tumor
• CEACAM5 protein, human
• Carcinoembryonic Antigen
• GPI-Linked Proteins
• L1CAM protein, human
• Neural Cell Adhesion Molecule L1

Topics

• Adult
• Aged
• Aged, 80 and over
• Biomarkers, Tumor (blood)
• Carcinoembryonic Antigen (blood)
• Case-Control Studies
• Colorectal Neoplasms (blood, diagnosis)
• Female
• GPI-Linked Proteins (blood)
• Humans
• Male
• Middle Aged
• Neural Cell Adhesion Molecule L1 (blood)
• Prognosis
• ROC Curve